New England Journal of Medicine · 2010 · 119 citations · 0 references
LawHealth LawHealth PolicyDrug LawHealth Care LawSubstance Use DisordersCannabis RegulationControlled Substance ReviewControlled SubstancesDrug EnforcementFederal Controlled Substance LawSubstance Abuse PreventionCannabis AbuseCannabis Public Health RegulationControlled Substances ActDrug Legalization PolicyMedical Cannabis OffensesMedical Cannabis RegulationPenaltiesTherapeutic Use Exemptions
The U.S. legal landscape surrounding "medical marijuana" is complex and rapidly changing. Fourteen states — California, Alaska, Oregon, Washington, Maine, Hawaii, Colorado, Nevada, Vermont, Montana, Rhode Island, New Mexico, Michigan, and most recently, New Jersey — have passed laws eliminating criminal penalties for using marijuana for medical purposes, and at least a dozen others are considering such legislation.1 Medical experts have also taken a fresh look at the evidence regarding the therapeutic use of marijuana,2,3 and the American Medical Association (AMA) recently adopted a resolution urging review of marijuana as a Schedule I controlled substance, noting it would support . . .